Antineutrophil cytoplasmic autoantibodies: How should the biologist manage them?

Clinical Reviews in Allergy and Immunology

Volumn 35, Issue 1-2, 2008, Pages 47-58

  Beauvillain, C ^a,b   Delneste, Y ^a   Renier, G ^b,c   Jeannin, P ^a,b   Subra, J F ^a,b   Chevailler, A ^a,b  

^a UNIVERSITÉ D'ANGERS   (France)

^b ANGERS UNIVERSITY HOSPITAL   (France)

^c UNIVERSITÉ D'ANGERS   (France)

Author keywords

Anti myeloperoxidase antibodies; Anti proteinase 3 antibodies; Antineutrophil cytoplasmic antibodies; Small vessel vasculitis

Indexed keywords

ALCOHOL; ANTIGEN; ANTINUCLEAR ANTIBODY; AZUROCIDIN; BACTERICIDAL INCREASING PERMEABILITY PROTEIN; CATHEPSIN G; DEFENSIN; ELASTASE; FORMALDEHYDE; IMMUNOSUPPRESSIVE AGENT; LACTOFERRIN; METHANOL; MYELOPEROXIDASE; NEUTROPHIL CYTOPLASMIC ANTIBODY; PROTEINASE INHIBITOR; UNCLASSIFIED DRUG; ANTIMICROBIAL CATIONIC PEPTIDE; BACTERICIDAL PERMEABILITY INCREASING PROTEIN; MYELOBLASTIN; PEROXIDASE; PLASMA PROTEIN;

ANTIBODY SPECIFICITY; ANTIBODY TITER; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; IMMUNE RESPONSE; IMMUNOBLOTTING; IMMUNOFLUORESCENCE; IMMUNOFLUORESCENCE MICROSCOPY; INFECTION; INFLAMMATION; LUNG HEMORRHAGE; MICROSCOPIC POLYANGIITIS; MULTIPLEX POLYMERASE CHAIN REACTION; NEUTROPHIL; PATIENT CARE; POLYMORPHONUCLEAR CELL; REVIEW; SENSITIVITY AND SPECIFICITY; SOLID PHASE SYNTHESIS; SUBACUTE ENDOCARDITIS; SYSTEMIC VASCULITIS; WEGENER GRANULOMATOSIS; FLUORESCENT ANTIBODY TECHNIQUE; IMMUNOLOGY;

ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; ANTIMICROBIAL CATIONIC PEPTIDES; BLOOD PROTEINS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HUMANS; IMMUNOBLOTTING; MYELOBLASTIN; NEUTROPHILS; PEROXIDASE;

EID: 55249101506     PISSN: 10800549     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12016-007-8071-9     Document Type: Review

References (79)

1. FJ van der Woude N Rasmussen S Lobatto A Wiik H Permin LA van Es M van der Giessen GK van der Hem TH The 1985 Antibodies against neutrophils and monocytes: tool for diagnosis and marker of disease activity in Wegener's granulomatosis Lancet 1 425 429
2. N Mohan GS Kerr 2001 Best Pract Res Clin Rheumatol 15 203 223
3. JC Jennette RJ Falk K Andrassy PA Bacon J Churg WL Gross EC Hagen GS Hoffman GG Hunder CG Kallenberg 1994 Nomenclature of systemic vasculitides. Proposal of an international consensus conference Arthritis Rheum 37 187 192
4. DJ Davies JE Moran JF Niall GB Ryan 1982 Segmental necrotizing glomerulonephritis with anti-neutrophil antibody: possible arbovirus aetiology? Br Med J 285 606
5. J Savige W Pollock M Trevisin 2005 What do antineutrophil cytoplasmic antibodies (ANCA) tell us? Best Pract Res Clin Rheumatol 19 263 276
6. IM Bajema EC Hagen F Ferrario E de Heer JA Bruijn 2001 Immunopathological aspects of systemic vasculitis Springer Semin Immunopathol 23 253 265
7. V Witko-Sarsat P Rieu B Descamps-Latscha P Lesavre L Halbwachs-Mecarelli 2000 Neutrophils: molecules, functions and pathophysiological aspects Lab Invest 80 617 653
8. RJ Falk RS Terrell LA Charles JC Jennette 1990 Anti-neutrophil cytoplasmic autoantibodies induce neutrophils to degranulate and produce oxygen radicals in vitro Proc Natl Acad Sci USA 87 4115 4119
9. DR Ralston CB Marsh MP Lowe MD Wewers 1997 Antineutrophil cytoplasmic antibodies induce monocyte IL-8 release. Role of surface proteinase-3, alpha1-antitrypsin, and Fcgamma receptors J Clin Invest 100 1416 1424
10. AS Lee JD Finkielman T Peikert AM Hummel MA Viss GL Jacob HA Homburger U Specks Wegener's Granulomatosis Etanercept Trial Research Group 2006 Agreement of anti-neutrophil cytoplasmic antibody measurements obtained from serum and plasma Clin Exp Immunol 146 15 20
11. A Wiik 1989 Delineation of a standard procedure for indirect immunofluorescence detection of ANCA Acta Pathol Microbiol Scand 97 12 13
12. RJ Falk JC Jennette 1988 Anti-neutrophil cytoplasmic autoantibodies with specificity for myeloperoxidase in patients with systemic vasculitis and idiopathic necrotizing and crescentic glomerulonephritis N Engl J Med 318 1651 1657
13. Wiik A, Rasmussen N, Wieslander J (1994) Methods to detect autoantibodies to neutrophilic granulocytes. In: van Venrooij WJ, Maini RN (eds) Manual of biological markers of diseases. Kluwer Academic Publishers, Dordrecht A9, pp 1-14
14. Wieslander J, Wiik A (1994) ANCA antigens: myeloperoxydase. In: van Venrooij WJ, Maini RN (eds) Manual of biological markers of diseases. Kluwer Academic Publishers, Dordrecht B7.2, pp 1-9
15. JA Savige B Paspaliaris R Silvestrini D Davies T Nikoloutsopoulos A Sturgess J Neil W Pollock K Dunster M Hendle 1998 A review of immunofluorescent patterns associated with antineutrophil cytoplasmic antibodies (ANCA) and their differentiation from other antibodies J Clin Pathol 51 568 575
16. A Chevailler LH Noel G Renier M Gardembas-Pain JF Subra P Nusbaum D Hurez P Lesavre 1992 Unambiguous determination of anti-neutrophil cytoplasm antibodies (ANCA) specificity by immunofluorescence on chronic myelocytic leukemia cells J Immunol Methods 147 101 109
17. J Savige D Gillis E Benson D Davies V Esnault RJ Falk EC Hagen D Jayne JC Jennette B Paspaliaris W Pollock C Pusey CO Savage R Silvestrini F van der Woude J Wieslander A Wiik 1999 International Consensus Statement on Testing and Reporting of Antineutrophil Cytoplasmic Antibodies (ANCA) Am J Clin Pathol 111 507 513
18. A Wiik 2001 Anti-neutrophil cytoplasmic antibodies tests: which tests should be used in practice? Internal Med 40 446 470
19. RC Kao NG Wehner KM Skubitz BH Gray JR Hoidal 1988 A distinct human polymorphonuclear leukocyte proteinase that produces emphysema in hamster J Clin Invest 82 1963 1973
20. R Goldschmeding CE van der Schoot D ten Bokkell Huinink CE Hack ME van den Ende CGM Kallenberg AE von dem Borne 1989 Wegener's granulomatosis autoantibodies identify a novel diisopropylfluorophosphate-binding protein in the lysosomes of normal human neutrophils J Clin Invest 84 1577 1587
21. YM van der Geld PC Limburg CGM Kallenberg 2001 Proteinase 3, Wegener's autoantigen: from gene to antigen J Leukoc Biol 69 177 190
22. A Wiik 2001 Methods for the detection of anti-neutrophil cytoplasmic antibodies. Recommandation for clinical use of ANCA serology and laboratory efforts to optimize the informative value of ANCA test results Springer Semin Immunopathol 23 217 229
23. Wieslander J, Wiik A (1994) ANCA antigens: proteinase 3. In: van Venrooij WJ, Maini RN (eds) Manual of biological markers of diseases. Kluwer Academic Publishers, Dordrecht B7.1, pp 1-9
24. Gross WL, Csernok E, Szymkowiak CH (1996) Antineutrophil cytoplasmic autoantibodies with specificity for proteinase 3. In: Peter JB, Shoenfeld Y (eds) Autoantibodies. Elsevier, Amsterdam, pp 61-67
25. J Sun DN Fass MA Viss AM Hummel H Tang HA Homburger U Specks 1998 A proportion of proteinase 3 (PR3)-specific anti-neutrophil cytoplasmic antibodies (ANCA) only react with PR3 after cleavage of its N-terminal activation dipeptide Clin Exp Immunol 114 320 326
26. MEJ Taekema-Roelvink C van Kooten CA Verburgh MR Daha 2001 Role of proteinase 3 in activation of endothelium Springer Semin Immunopathol 23 299 314
27. L Halbwachs-Mecarelli G Bessou P Lesavre S Lopez V Witko-Sarsat 1995 Bimodal distribution of proteinase 3 (PR3) surface expression reflects a constitutive heterogeneity in the polymorphonuclear neutrophil pool FEBS Lett 374 29 33
28. V Witko-Sarsat P Lesavre S Lopez G Bessou C Hieblot B Prum LH Noël L Guillevin P Ravaud I Sermet-Gaudelus J Timsit JP Grünfeld L Halbwachs-Mecarelli 1999 A large subset of neutrophils expressing membrane proteinase 3 is a risk factor for vasculitis and rheumatoid arthritis J Am Soc Nephrol 10 1224 1233
29. VL Esnault A Testa M Audrain C Roge M Hamidou JH Barrier R Sesboüé JP Martin P Lesavre 1993 Alpha1-anti-trypsin genetic polymorphism in ANCA positive systemic vasculitis Kidney Int 43 1323 1332
30. MA Audrain R Sesboue TAR Baranger J Elliott A Testa JP Martin CM Lockwood VL Esnault 2001 Analysis of anti-neutrophil antibodies (ANCA): frequency and specificity in a sample of 191 homozygous (PiZZ) alpha-1-antitrypsin-deficient subjects Nephrol Dial Transplant 16 39 44
31. Wieslander J, Wiik A (1994) ANCA antigens: myeloperoxidase. In: van Venrooij WJ, Maini RN (eds) Manual of biological markers of diseases. Kluwer Academic Publishers, Dordrecht B7.2, pp 1-9
32. Kallenberg CGM (1996) Antineutrophil cytoplasmic autoantibodies with specificity for myeloperoxidase. In: Peter JB, Shoenfeld Y (eds) Autoantibodies. Elsevier, Amsterdam, pp 53-60
33. Kallenberg CGM (2007) Antineutrophil cytoplasmic autoantibodies with specificity for myeloperoxidase. In: Shoenfeld Y, Gershwin ME, Meroni PL (eds) Autoantibodies. Elsevier, Amsterdam, pp 95-103
34. MM Boomsma CA Stegeman WW Oost-Kort CGM Kallenberg N Moguilevsky PC Limburg JW Tervaert 2001 Native and recombinant proteins to analyze autoantibodies to myeloperoxidase in pauci-immune crescentic glomerulonephritis J Immunol Methods 254 47 58
35. RJ Falk M Becker R Terrell JC Jennette 1992 Anti-myeloperoxidase autoantibodies react with native but not denatured myeloperoxidase Clin Exp Immunol 89 274 278
36. M Segelmark B Baslund J Wieslander 1994 Some patients with antimyeloperoxidase autoantibodies have a cANCA pattern Clin Exp Immunol 96 458 465
37. Chevailler A, Subra JF, Renier G, Carrère F, Hurez D (1993) Anti-myeloperoxidase antibodies and associated diseases. In: Gross WL (ed) ANCA- associated vasculitides: immunological and clinical aspects. Plenum Press, New York, pp 263-266
38. EC Hagen MR Daha J Hermans K Andrassy E Csernok G Gaskin P Lesavre J Lüdemann N Rasmussen RA Sinico A Wiik FJ van der Woude 1998 The diagnostic value of standardized assays for anti-neutrophil cytoplasmic antibodies (ANCA) in idiopathic systemic vasculitis. Results of an international collaborative study Kidney Int 53 743 753
39. Zhao MH, Lockwood CM (1996) Antineutrophil cytoplasmic autoantibodies with specificity other than PR3 and MPO (x-ANCA). In: Peter JB, Shoenfeld Y (eds) Autoantibodies. Elsevier, Amsterdam, pp 68-73
40. MH Zhao SJ Jones CM Lockwood 1995 Bactericidal/permeability increasing protein (BPI) is an important antigen for anti-neutrophil cytoplasmic autoantibodies (ANCA) in vasculitis Clin Exp Immunol 99 49 56
41. H Schultz J Weiss SF Carroll WL Gross 2001 The endotoxin bactericidal/permeability increasing protein (BPI): a target of autoantibodies J Leukoc Biol 69 505 512
42. M Segelmark K Westman J Wieslander 2000 How and why should we detect ANCA? Clin Exp Rheumatol 18 629 635
43. MH Zhao CM Lockwood 1996 Azurocidin is a novel antigen for anti-neutrophil cytoplasmic antibodies (ANCA) in systemic vasculitis Clin Exp Immunol 103 397 402
44. L Nassberger H Jonsson AG Sjoholm G Sturfelt A Heubner 1989 Circulating antielastase in systemic lupus erythematosus Lancet 1 509
45. L Halbwachs-Mecarelli P Nusbaum LH Noel D Reumaux S Erlinger JP Grünfeld P Lesavre 1992 Antineutrophil cytoplasmic antibodies (ANCA) directed against cathepsin G in ulcerative colitis, Crohn's disease and primary sclerosing cholangitis Clin Exp Immunol 90 79 84
46. IE Corremans EC Hagen MR Daha EA van der Voort C Kleijburg-van der Keur FC Breedveld 1992 Antilactoferrin antibodies in patients with arthritis are associated with vasculitis Arthritis Rheum 35 1466 1475
47. MY Gallin AB Jacobi DW Buttner O Schoenberger T Marti KDA Ertman 1995 Human autoantibody to defensin: disease association with hyperactive onchocerciasis J Exp Med 182 41 47
48. Schmitt WH, Csernok E, Flesch BK, Hauschild S, Gross WL (1993) Autoantibodies directed against lysozyme: a new target antigen for antineutrophil cytoplasmic antibodies (ANCA). In: Gross WL (ed) ANCA- associated vasculitides: immunological and clinical aspects. Plenum Press, New York, pp 267-272
49. L Nassberger A Ljungh G Schumacher B Kollberg 1992 β-glucuronidase in ulcerative colitis Lancet 340 734 735
50. FD Moodie B Leaker G Cambridge NF Totty AW Segal 1993 Alpha-enolase: a novel cytosolic autoantigen in ANCA positive vasculitis Kidney Int 43 675 681
51. R Kain K Matsui M Exner S Binder G Schaffner EM Sommer D Kerjaschki 1995 A novel class of autoantigens of antineutrophil cytoplasmic antibodies in necrotizing and crescentic glomerulonephritis: the lysosomal membrane glycoprotein h-lamp-2 in neutrophil granules and a related membrane proteine in glomerular endothelial cells J Exp Med 181 585 597
52. MV Talor JH Stone J Stebbing J Barin NR Rose CL Burek 2007 Antibodies to selected minor target antigens in patients with anti-neutrophil cytoplasmic antibodies (ANCA) Clin Exp Immunol 150 42 48
53. EC Hagen MR Daha J Hermans K Andrassy E Csernok G Gaskin P Lesavre J Lüdemann N Rasmussen RA Sinico A Wiik FJ van der Woude 1998 The diagnostic value of standardized assays for anti-neutrophil cytoplasmic antibodies (ANCA) in idiopathic systemic vasculitis. Results of an international collaborative study Kidney Int 53 743 753
54. FJ van der Woude MR Daha LA van Es 1989 The current status of neutrophil cytoplasmic antibodies Clin Exp Immunol 78 143 148
55. EC Hagen K Andrassy E Chernok MR Daha G Gaskin W Gross P Lesavre J Lüdemann CD Pusey N Rasmussen 1993 The value of indirect immunofluorescence and solid phase techniques for ANCA detection. A report on the first phase of an international cooperative study on the standardization of ANCA assays J Immunol Methods 159 1 16
56. EC Hagen K Andrassy E Csernok MR Daha G Gaskin W Gross B Hansen Z Heigl J Hermans D Jayne CG Kallenberg P Lesavre CM Lockwood J Lüdemann F Mascart-Lemone E Mirapeix CD Pusey N Rasmussen RA Sinico A Tzioufas J Wieslander A Wiik FJ Van der Woude 1996 Development of solid phase assays for the detection of anti-neutrophil cytoplasmic antibodies (ANCA). A report on the second phase of an international cooperative study on the stardardization of ANCA assays J Immunol Methods 196 1 15
57. MA Audrain D Reumaux F Gerson P Duthilleul A Wiik JY Muller VL Esnault 1999 Contamination of commercially purified myeloperoxidase preparations by lactoferrin J Immunol Methods 222 219 220
58. HS Jethwa PH Nachman RJ Falk JC Jennette 2000 False-positive myeloperoxidase binding activity due to DNA/anti-DNA antibody complexes: a source for analytical error in serologic evaluation of anti-neutrophil cytoplasmic antibodies Clin Exp Immunol 121 544 550
59. KW Westman D Selga P Bygren M Segelmark B Baslund A Wiik J Wieslander 1998 Clinical evaluation of a capture ELISA for detection of proteinase-3 antineutrophil cytoplasmic antibody Kidney Int 53 1230 1236
60. J Damoiseaux M Vaessen Y Knapen E Csernok CA Stegeman P Van Paassen JW Cohen Tervaert 2007 Evaluation of the FIDIS vasculitis multiplex immunoassay for diagnosis and follow-up of ANCA-associated vasculitis and Goodpasture's disease Ann N Y Acad Sci 1109 454 463
61. L Lim J Taylor J Schmitz J Folds A Wilkman RJ Falk JC Jennette 1999 Diagnostic usefulness of antineutrophil cytoplasmic antibody serology Am J Clin Path 111 363 369
62. JF Subra C Michelet J Laporte F Carrere P Reboul F Cartier JP Saint-André A Chevailler 1998 The presence of cytoplasmic antineutrophil cytoplasmic antibodies (c-ANCA) in the course of subacute bacterial endocarditis with glomerular involvement, coincedence or association Clin Nephrol 49 15 18
63. A Soto C Jorgensen F Oksman LH Noel J Sany 1994 Endocarditis associated with ANCA Clin Exp Rheumatol 12 203 204
64. JD Finkielman AS Lee AM Hummel MA Viss GL Jacob HA Homburger T Peikert GS Hoffman PA Merkel R Spiera EW St Clair JC Davis Jr WJ McCune AK Tibbs SR Ytterberg JH Stone U Specks WGET Research Group 2007 ANCA are detectable in nearly all patients with active severe Wegener's granulomatosis Am J Med 120 643
65. HK Choi PA Merkel AM Walker JL Niles 2000 Drug-associated antineutrophil cytoplasmic antibodies-positive vasculitis: prevalence among patients with high titers of antimyeloperoxidase antibodies Arthritis Rheum 43 405 413
66. J De'Oliviera G Gaskin A Dash AJ Rees CD Pusey 1995 Relationship between disease activity and anti-neutrophil cytoplasmic antibody concentration in long-term management of systemic vasculitis Am J Kidney Dis 25 380 389
67. JW Cohen-Tervaert MG Huitema RJ Hene WJ Sluiter TH The GK van der Hem CG Kallenberg 1990 Prevention of relapses in Wegener's granulomatosis by treatment based on anti-neutrophil cytoplasmic antibodies titre Lancet 336 709 711
68. GS Kerr TA Fleisher CW Hallahan RY Leavitt AS Fauci GS Hoffman 1993 Limited prognostic value of changes in antineutrophil cytoplasmic antibody titer in patients with Wegener's granulomatosis Arthritis Rheum 36 365 371
69. Mukhtyar C, Flossmann O, Hellmich B, Bacon PA, Cid MC, Cohen Tervaert JW, Gross WL, Guillevin L, Jayne DR, Mahr A, Merkel PA, Raspe H, Scott DG, Witter J, Yazici H, Luqmani RA (2007) Outcomes from studies of Antineutrophil Cytoplasm Antibody Associated Vasculitis: a systematic review by the EULAR Systemic Vasculitis Task Force. Ann Rheum Dis Oct 2; [Epub ahead of print]
70. D Sinclair M Saas JM Stevens 2004 The effect of a symptom related "gating policy" on ANCA requests in routine clinical practice J Clin Pathol 57 131 134
71. CA Stegeman CGM Kallenberg 2001 Clinical aspects of primary vasculitis Springer Semin Immunopathol 23 231 251
72. Radice A, Sabadini E, Sinico RA (2007) Antineutrophil cytoplasmic autoantibodies with specificity for proteinase 3. In: Shoenfeld Y, Gershwin ME, Meroni PL (eds) Autoantibodies. Elsevier, Amsterdam, pp 105-110
73. Aries P, Csernok E, Gross L (2007) Antineutrophil cytoplasmic autoantibodies with specificity for proteinase 3. In: Shoenfeld Y, Gershwin ME, Meroni PL (eds) Autoantibodies. Elsevier, Amsterdam, pp 119-126
74. WF Pendergraft 3rd GA Preston RR Shah A Tropsha CW Carter Jr JC Jennette RJ Falk 2004 Autoimmunity is triggered by cPR-3(105-201), a protein complementary to human autoantigen proteinase-3 Nat Med 10 72 79
75. A Chevailler F Carrère G Renier D Hurez JF Subra P Reboul P Riberi C Masson 1994 Silicon nephropathy and myeloperoxydase antibodies Ann Rheum Dis 53 781 782
76. G Gregorini P Tira J Frizza PC D'Haese MM Elseviers G Nuyts R Maiorca ME De Broe 1997 ANCA-associated diseases and silica exposure Clin Rev Allergy Immunol 15 21 40
77. SL Hogan GS Cooper DA Savitz LA Nylander-French CG Parks H Chin CE Jennette S Lionaki JC Jennette RJ Falk 2007 Association of silica exposure with anti-neutrophil cytoplasmic autoantibody small-vessel vasculitis: a population-based, case-control study Clin J Am Soc Nephrol 2 290 299
78. ME Griffith CD Pusey 2001 Cellular aspects of vasculitis- T cell-mediated aspects Springer Semin Immunopathol 23 287 298
79. JF Subra G Renier P Reboul F Tollis R Boivinet P Schwartz A Chevailler 2001 Lymphopenia in occupational pulmonary silicosis with or without autoimmune disease Clin Exp Immunol 126 540 544